Investment Summary |
|
|---|---|
| Date | 2022-04-27 |
| Target | ElaN Languages |
| Sector | Internet Software and Services |
| Investor(s) | Andera Partners |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 98 of 104 |
| Sector (Internet Software and Services) | 1 of 1 |
| Type (Growth Capital) | 26 of 28 |
| Country (Belgium) | 9 of 9 |
| Year (2022) | 6 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-21 |
ERI
Fontenay-sous-Bois, France ERI is a provider of renovation, maintenance, and rehabilitation of all types of building for clients mainly composed of public and quasi-public operators. ERI was founded in 1957 and is based in Fontenay-sous-Bois, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-03 |
Tubulis
Munich, Germany Tubulis generates uniquely matched antibody-drug conjugates (ADCs) through the combination of novel proprietary technologies and disease-specific biologic insight. Tubulis was founded in 2018 and is based in Munich, Germany. |
Buy | - |
